 | • レポートコード：MR2211MG11893 • 出版社/出版日：Market Monitor Global / 2022年11月 • レポート形態：英文、PDF、124ページ • 納品方法：Eメール（納期：2-3日） • 産業分類：医療機器 |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥625,300 (USD4,225) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は次の情報を含め、ポイントオブケア迅速診断のグローバル市場規模と予測を記載しています。・ポイントオブケア迅速診断のグローバル市場：売上、2017年-2022年、2023年-2028年 ・ポイントオブケア迅速診断のグローバル市場：販売量、2017年-2022年、2023年-2028年 ・世界のトップ5企業、2021年 ポイントオブケア迅速診断のグローバル市場規模は2021年に000Mドルと評価され、予測期間中に000％のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「血糖検査」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。 ポイントオブケア迅速診断のグローバル主要企業は、Roche、Abbott、Johnson & Johnson、Siemens Healthcare、Danaher、Ascensia、Bio-Rad Laboratories、BioMerieux、Nova Biomedical、Trividia Health、Quidel、Accriva、OraSure Technologies、Helena Laboratories、A. Menarini Diagnostics、Abaxis (Zoetis)、Ortho Clinical Diagnostics、Phamatech、Chembio Diagnostics、Trinity Biotechなどです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。 マーケットモニターグローバル（MMG）社は、ポイントオブケア迅速診断のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のポイントオブケア迅速診断市場：タイプ別、2017年-2022年、2023年-2028年 世界のポイントオブケア迅速診断市場：タイプ別市場シェア、2021年 ・血糖検査、血液ガス・電解質分析、凝固迅速診断、心臓マーカー迅速診断、乱用薬物スクリーニング、食品病原体スクリーニング、ヘモグロビン診断、感染症検査、その他 世界のポイントオブケア迅速診断市場：用途別、2017年-2022年、2023年-2028年 世界のポイントオブケア迅速診断市場：用途別市場シェア、2021年 ・クリニック、病院、研究所、その他 世界のポイントオブケア迅速診断市場：地域・国別、2017年-2022年、2023年-2028年 世界のポイントオブケア迅速診断市場：地域別市場シェア、2021年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるポイントオブケア迅速診断のグローバル売上、2017年-2022年 ・主要企業におけるポイントオブケア迅速診断のグローバル売上シェア、2021年 ・主要企業におけるポイントオブケア迅速診断のグローバル販売量、2017年-2022年 ・主要企業におけるポイントオブケア迅速診断のグローバル販売量シェア、2021年 さらに、当レポートは主要企業のプロファイルを提示します。 Roche、Abbott、Johnson & Johnson、Siemens Healthcare、Danaher、Ascensia、Bio-Rad Laboratories、BioMerieux、Nova Biomedical、Trividia Health、Quidel、Accriva、OraSure Technologies、Helena Laboratories、A. Menarini Diagnostics、Abaxis (Zoetis)、Ortho Clinical Diagnostics、Phamatech、Chembio Diagnostics、Trinity Biotech ************************************************************* ・調査・分析レポートの概要 ポイントオブケア迅速診断市場の定義 市場セグメント 世界のポイントオブケア迅速診断市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のポイントオブケア迅速診断市場規模 世界のポイントオブケア迅速診断市場規模：2021年 VS 2028年 世界のポイントオブケア迅速診断市場規模と予測 2017年-2028年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのポイントオブケア迅速診断の売上 グローバルトップ3およびトップ5企業、2021年売上ベース グローバル企業のポイントオブケア迅速診断製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：血糖検査、血液ガス・電解質分析、凝固迅速診断、心臓マーカー迅速診断、乱用薬物スクリーニング、食品病原体スクリーニング、ヘモグロビン診断、感染症検査、その他 ポイントオブケア迅速診断のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：クリニック、病院、研究所、その他 ポイントオブケア迅速診断の用途別グローバル売上・予測 ・地域別市場分析 地域別ポイントオブケア迅速診断市場規模 2021年と2028年 地域別ポイントオブケア迅速診断売上・予測 北米市場 - アメリカのポイントオブケア迅速診断市場規模2017年-2028年 - カナダのポイントオブケア迅速診断市場規模2017年-2028年 - メキシコのポイントオブケア迅速診断市場規模2017年-2028年 ヨーロッパ市場 - ドイツのポイントオブケア迅速診断市場規模2017年-2028年 - フランスのポイントオブケア迅速診断市場規模2017年-2028年 - イギリスのポイントオブケア迅速診断市場規模2017年-2028年 - イタリアのポイントオブケア迅速診断市場規模2017年-2028年 - ロシアのポイントオブケア迅速診断市場規模2017年-2028年 アジア市場 - 中国のポイントオブケア迅速診断市場規模2017年-2028年 - 日本のポイントオブケア迅速診断市場規模2017年-2028年 - 韓国のポイントオブケア迅速診断市場規模2017年-2028年 - 東南アジアのポイントオブケア迅速診断市場規模2017年-2028年 - インドのポイントオブケア迅速診断市場規模2017年-2028年 南米市場 - ブラジルのポイントオブケア迅速診断市場規模2017年-2028年 - アルゼンチンのポイントオブケア迅速診断市場規模2017年-2028年 中東・アフリカ市場 - トルコのポイントオブケア迅速診断市場規模2017年-2028年 - イスラエルのポイントオブケア迅速診断市場規模2017年-2028年 - サウジアラビアのポイントオブケア迅速診断市場規模2017年-2028年 - UAEのポイントオブケア迅速診断市場規模2017年-2028年 ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Roche、Abbott、Johnson & Johnson、Siemens Healthcare、Danaher、Ascensia、Bio-Rad Laboratories、BioMerieux、Nova Biomedical、Trividia Health、Quidel、Accriva、OraSure Technologies、Helena Laboratories、A. Menarini Diagnostics、Abaxis (Zoetis)、Ortho Clinical Diagnostics、Phamatech、Chembio Diagnostics、Trinity Biotech ... |
Point of Care Rapid Diagnosis is defined as medical diagnostic testing at or near the point of care—that is, at the time and place of patient care.This contrasts with the historical pattern in which testing was wholly or mostly confined to the medical laboratory, which entailed sending off specimens away from the point of care and then waiting hours or days to learn the results. The driving notion behind Point of Care Rapid Diagnosis is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for better immediate clinical management decisions to be made. Point of Care Rapid Diagnosis includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, Sepsis Testing, Upper Respiratory Tract Infections Testing, Antibiotic Resistance Testing, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening. Point of Care Rapid Diagnosis is often accomplished through the use of transportable, portable, and handheld instruments and test kits.Small bench analyzers or fixed equipment can also be used when a handheld device is not available—the goal is to collect the specimen and obtain the results in a very short period of time at or near the location of the patient so that the treatment plan can be adjusted as necessary before the patient leaves.Cheaper, faster, and smarter Point of Care Rapid Diagnosis devices have increased the use of Point of Care Rapid Diagnosis approaches by making it cost-effective for many diseases.
This report contains market size and forecasts of Point of Care Rapid Diagnosis in global, including the following market information:
Global Point of Care Rapid Diagnosis Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Point of Care Rapid Diagnosis Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Point of Care Rapid Diagnosis companies in 2021 (%)
The global Point of Care Rapid Diagnosis market was valued at US$ million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Blood Glucose Testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Point of Care Rapid Diagnosis include Roche, Abbott, Johnson & Johnson, Siemens Healthcare, Danaher, Ascensia, Bio-Rad Laboratories, BioMerieux and Nova Biomedical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Point of Care Rapid Diagnosis manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Point of Care Rapid Diagnosis Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Point of Care Rapid Diagnosis Market Segment Percentages, by Type, 2021 (%)
Blood Glucose Testing
Blood Gas and Electrolytes Analysis
Rapid Coagulation Testing
Rapid Cardiac Markers Diagnostic
Drugs of Abuse Screening
Food Pathogens Screening
Hemoglobin Diagnostics
Infectious Disease Testing
Others
Global Point of Care Rapid Diagnosis Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Point of Care Rapid Diagnosis Market Segment Percentages, by Application, 2021 (%)
Clinics
Hospitals
Laboratory
Others
Global Point of Care Rapid Diagnosis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Point of Care Rapid Diagnosis Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Point of Care Rapid Diagnosis revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Point of Care Rapid Diagnosis revenues share in global market, 2021 (%)
Key companies Point of Care Rapid Diagnosis sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Point of Care Rapid Diagnosis sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Abbott
Johnson & Johnson
Siemens Healthcare
Danaher
Ascensia
Bio-Rad Laboratories
BioMerieux
Nova Biomedical
Trividia Health
Quidel
Accriva
OraSure Technologies
Helena Laboratories
A. Menarini Diagnostics
Abaxis (Zoetis)
Ortho Clinical Diagnostics
Phamatech
Chembio Diagnostics
Trinity Biotech
ELITech Group
Response Biomedical
Princeton BioMeditech
Alfa Wassermann
ARKRAY
1 Introduction to Research & Analysis Reports
1.1 Point of Care Rapid Diagnosis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Point of Care Rapid Diagnosis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Point of Care Rapid Diagnosis Overall Market Size
2.1 Global Point of Care Rapid Diagnosis Market Size: 2021 VS 2028
2.2 Global Point of Care Rapid Diagnosis Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Point of Care Rapid Diagnosis Sales: 2017-2028
3 Company Landscape
3.1 Top Point of Care Rapid Diagnosis Players in Global Market
3.2 Top Global Point of Care Rapid Diagnosis Companies Ranked by Revenue
3.3 Global Point of Care Rapid Diagnosis Revenue by Companies
3.4 Global Point of Care Rapid Diagnosis Sales by Companies
3.5 Global Point of Care Rapid Diagnosis Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Point of Care Rapid Diagnosis Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Point of Care Rapid Diagnosis Product Type
3.8 Tier 1, Tier 2 and Tier 3 Point of Care Rapid Diagnosis Players in Global Market
3.8.1 List of Global Tier 1 Point of Care Rapid Diagnosis Companies
3.8.2 List of Global Tier 2 and Tier 3 Point of Care Rapid Diagnosis Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Point of Care Rapid Diagnosis Market Size Markets, 2021 & 2028
4.1.2 Blood Glucose Testing
4.1.3 Blood Gas and Electrolytes Analysis
4.1.4 Rapid Coagulation Testing
4.1.5 Rapid Cardiac Markers Diagnostic
4.1.6 Drugs of Abuse Screening
4.1.7 Food Pathogens Screening
4.1.8 Hemoglobin Diagnostics
4.1.9 Infectious Disease Testing
4.1.10 Others
4.2 By Type – Global Point of Care Rapid Diagnosis Revenue & Forecasts
4.2.1 By Type – Global Point of Care Rapid Diagnosis Revenue, 2017-2022
4.2.2 By Type – Global Point of Care Rapid Diagnosis Revenue, 2023-2028
4.2.3 By Type – Global Point of Care Rapid Diagnosis Revenue Market Share, 2017-2028
4.3 By Type – Global Point of Care Rapid Diagnosis Sales & Forecasts
4.3.1 By Type – Global Point of Care Rapid Diagnosis Sales, 2017-2022
4.3.2 By Type – Global Point of Care Rapid Diagnosis Sales, 2023-2028
4.3.3 By Type – Global Point of Care Rapid Diagnosis Sales Market Share, 2017-2028
4.4 By Type – Global Point of Care Rapid Diagnosis Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application – Global Point of Care Rapid Diagnosis Market Size, 2021 & 2028
5.1.2 Clinics
5.1.3 Hospitals
5.1.4 Laboratory
5.1.5 Others
5.2 By Application – Global Point of Care Rapid Diagnosis Revenue & Forecasts
5.2.1 By Application – Global Point of Care Rapid Diagnosis Revenue, 2017-2022
5.2.2 By Application – Global Point of Care Rapid Diagnosis Revenue, 2023-2028
5.2.3 By Application – Global Point of Care Rapid Diagnosis Revenue Market Share, 2017-2028
5.3 By Application – Global Point of Care Rapid Diagnosis Sales & Forecasts
5.3.1 By Application – Global Point of Care Rapid Diagnosis Sales, 2017-2022
5.3.2 By Application – Global Point of Care Rapid Diagnosis Sales, 2023-2028
5.3.3 By Application – Global Point of Care Rapid Diagnosis Sales Market Share, 2017-2028
5.4 By Application – Global Point of Care Rapid Diagnosis Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region – Global Point of Care Rapid Diagnosis Market Size, 2021 & 2028
6.2 By Region – Global Point of Care Rapid Diagnosis Revenue & Forecasts
6.2.1 By Region – Global Point of Care Rapid Diagnosis Revenue, 2017-2022
6.2.2 By Region – Global Point of Care Rapid Diagnosis Revenue, 2023-2028
6.2.3 By Region – Global Point of Care Rapid Diagnosis Revenue Market Share, 2017-2028
6.3 By Region – Global Point of Care Rapid Diagnosis Sales & Forecasts
6.3.1 By Region – Global Point of Care Rapid Diagnosis Sales, 2017-2022
6.3.2 By Region – Global Point of Care Rapid Diagnosis Sales, 2023-2028
6.3.3 By Region – Global Point of Care Rapid Diagnosis Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country – North America Point of Care Rapid Diagnosis Revenue, 2017-2028
6.4.2 By Country – North America Point of Care Rapid Diagnosis Sales, 2017-2028
6.4.3 US Point of Care Rapid Diagnosis Market Size, 2017-2028
6.4.4 Canada Point of Care Rapid Diagnosis Market Size, 2017-2028
6.4.5 Mexico Point of Care Rapid Diagnosis Market Size, 2017-2028
6.5 Europe
6.5.1 By Country – Europe Point of Care Rapid Diagnosis Revenue, 2017-2028
6.5.2 By Country – Europe Point of Care Rapid Diagnosis Sales, 2017-2028
6.5.3 Germany Point of Care Rapid Diagnosis Market Size, 2017-2028
6.5.4 France Point of Care Rapid Diagnosis Market Size, 2017-2028
6.5.5 U.K. Point of Care Rapid Diagnosis Market Size, 2017-2028
6.5.6 Italy Point of Care Rapid Diagnosis Market Size, 2017-2028
6.5.7 Russia Point of Care Rapid Diagnosis Market Size, 2017-2028
6.5.8 Nordic Countries Point of Care Rapid Diagnosis Market Size, 2017-2028
6.5.9 Benelux Point of Care Rapid Diagnosis Market Size, 2017-2028
6.6 Asia
6.6.1 By Region – Asia Point of Care Rapid Diagnosis Revenue, 2017-2028
6.6.2 By Region – Asia Point of Care Rapid Diagnosis Sales, 2017-2028
6.6.3 China Point of Care Rapid Diagnosis Market Size, 2017-2028
6.6.4 Japan Point of Care Rapid Diagnosis Market Size, 2017-2028
6.6.5 South Korea Point of Care Rapid Diagnosis Market Size, 2017-2028
6.6.6 Southeast Asia Point of Care Rapid Diagnosis Market Size, 2017-2028
6.6.7 India Point of Care Rapid Diagnosis Market Size, 2017-2028
6.7 South America
6.7.1 By Country – South America Point of Care Rapid Diagnosis Revenue, 2017-2028
6.7.2 By Country – South America Point of Care Rapid Diagnosis Sales, 2017-2028
6.7.3 Brazil Point of Care Rapid Diagnosis Market Size, 2017-2028
6.7.4 Argentina Point of Care Rapid Diagnosis Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Point of Care Rapid Diagnosis Revenue, 2017-2028
6.8.2 By Country – Middle East & Africa Point of Care Rapid Diagnosis Sales, 2017-2028
6.8.3 Turkey Point of Care Rapid Diagnosis Market Size, 2017-2028
6.8.4 Israel Point of Care Rapid Diagnosis Market Size, 2017-2028
6.8.5 Saudi Arabia Point of Care Rapid Diagnosis Market Size, 2017-2028
6.8.6 UAE Point of Care Rapid Diagnosis Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Point of Care Rapid Diagnosis Major Product Offerings
7.1.4 Roche Point of Care Rapid Diagnosis Sales and Revenue in Global (2017-2022)
7.1.5 Roche Key News
7.2 Abbott
7.2.1 Abbott Corporate Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Point of Care Rapid Diagnosis Major Product Offerings
7.2.4 Abbott Point of Care Rapid Diagnosis Sales and Revenue in Global (2017-2022)
7.2.5 Abbott Key News
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Corporate Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Point of Care Rapid Diagnosis Major Product Offerings
7.3.4 Johnson & Johnson Point of Care Rapid Diagnosis Sales and Revenue in Global (2017-2022)
7.3.5 Johnson & Johnson Key News
7.4 Siemens Healthcare
7.4.1 Siemens Healthcare Corporate Summary
7.4.2 Siemens Healthcare Business Overview
7.4.3 Siemens Healthcare Point of Care Rapid Diagnosis Major Product Offerings
7.4.4 Siemens Healthcare Point of Care Rapid Diagnosis Sales and Revenue in Global (2017-2022)
7.4.5 Siemens Healthcare Key News
7.5 Danaher
7.5.1 Danaher Corporate Summary
7.5.2 Danaher Business Overview
7.5.3 Danaher Point of Care Rapid Diagnosis Major Product Offerings
7.5.4 Danaher Point of Care Rapid Diagnosis Sales and Revenue in Global (2017-2022)
7.5.5 Danaher Key News
7.6 Ascensia
7.6.1 Ascensia Corporate Summary
7.6.2 Ascensia Business Overview
7.6.3 Ascensia Point of Care Rapid Diagnosis Major Product Offerings
7.6.4 Ascensia Point of Care Rapid Diagnosis Sales and Revenue in Global (2017-2022)
7.6.5 Ascensia Key News
7.7 Bio-Rad Laboratories
7.7.1 Bio-Rad Laboratories Corporate Summary
7.7.2 Bio-Rad Laboratories Business Overview
7.7.3 Bio-Rad Laboratories Point of Care Rapid Diagnosis Major Product Offerings
7.7.4 Bio-Rad Laboratories Point of Care Rapid Diagnosis Sales and Revenue in Global (2017-2022)
7.7.5 Bio-Rad Laboratories Key News
7.8 BioMerieux
7.8.1 BioMerieux Corporate Summary
7.8.2 BioMerieux Business Overview
7.8.3 BioMerieux Point of Care Rapid Diagnosis Major Product Offerings
7.8.4 BioMerieux Point of Care Rapid Diagnosis Sales and Revenue in Global (2017-2022)
7.8.5 BioMerieux Key News
7.9 Nova Biomedical
7.9.1 Nova Biomedical Corporate Summary
7.9.2 Nova Biomedical Business Overview
7.9.3 Nova Biomedical Point of Care Rapid Diagnosis Major Product Offerings
7.9.4 Nova Biomedical Point of Care Rapid Diagnosis Sales and Revenue in Global (2017-2022)
7.9.5 Nova Biomedical Key News
7.10 Trividia Health
7.10.1 Trividia Health Corporate Summary
7.10.2 Trividia Health Business Overview
7.10.3 Trividia Health Point of Care Rapid Diagnosis Major Product Offerings
7.10.4 Trividia Health Point of Care Rapid Diagnosis Sales and Revenue in Global (2017-2022)
7.10.5 Trividia Health Key News
7.11 Quidel
7.11.1 Quidel Corporate Summary
7.11.2 Quidel Point of Care Rapid Diagnosis Business Overview
7.11.3 Quidel Point of Care Rapid Diagnosis Major Product Offerings
7.11.4 Quidel Point of Care Rapid Diagnosis Sales and Revenue in Global (2017-2022)
7.11.5 Quidel Key News
7.12 Accriva
7.12.1 Accriva Corporate Summary
7.12.2 Accriva Point of Care Rapid Diagnosis Business Overview
7.12.3 Accriva Point of Care Rapid Diagnosis Major Product Offerings
7.12.4 Accriva Point of Care Rapid Diagnosis Sales and Revenue in Global (2017-2022)
7.12.5 Accriva Key News
7.13 OraSure Technologies
7.13.1 OraSure Technologies Corporate Summary
7.13.2 OraSure Technologies Point of Care Rapid Diagnosis Business Overview
7.13.3 OraSure Technologies Point of Care Rapid Diagnosis Major Product Offerings
7.13.4 OraSure Technologies Point of Care Rapid Diagnosis Sales and Revenue in Global (2017-2022)
7.13.5 OraSure Technologies Key News
7.14 Helena Laboratories
7.14.1 Helena Laboratories Corporate Summary
7.14.2 Helena Laboratories Business Overview
7.14.3 Helena Laboratories Point of Care Rapid Diagnosis Major Product Offerings
7.14.4 Helena Laboratories Point of Care Rapid Diagnosis Sales and Revenue in Global (2017-2022)
7.14.5 Helena Laboratories Key News
7.15 A. Menarini Diagnostics
7.15.1 A. Menarini Diagnostics Corporate Summary
7.15.2 A. Menarini Diagnostics Business Overview
7.15.3 A. Menarini Diagnostics Point of Care Rapid Diagnosis Major Product Offerings
7.15.4 A. Menarini Diagnostics Point of Care Rapid Diagnosis Sales and Revenue in Global (2017-2022)
7.15.5 A. Menarini Diagnostics Key News
7.16 Abaxis (Zoetis)
7.16.1 Abaxis (Zoetis) Corporate Summary
7.16.2 Abaxis (Zoetis) Business Overview
7.16.3 Abaxis (Zoetis) Point of Care Rapid Diagnosis Major Product Offerings
7.16.4 Abaxis (Zoetis) Point of Care Rapid Diagnosis Sales and Revenue in Global (2017-2022)
7.16.5 Abaxis (Zoetis) Key News
7.17 Ortho Clinical Diagnostics
7.17.1 Ortho Clinical Diagnostics Corporate Summary
7.17.2 Ortho Clinical Diagnostics Business Overview
7.17.3 Ortho Clinical Diagnostics Point of Care Rapid Diagnosis Major Product Offerings
7.17.4 Ortho Clinical Diagnostics Point of Care Rapid Diagnosis Sales and Revenue in Global (2017-2022)
7.17.5 Ortho Clinical Diagnostics Key News
7.18 Phamatech
7.18.1 Phamatech Corporate Summary
7.18.2 Phamatech Business Overview
7.18.3 Phamatech Point of Care Rapid Diagnosis Major Product Offerings
7.18.4 Phamatech Point of Care Rapid Diagnosis Sales and Revenue in Global (2017-2022)
7.18.5 Phamatech Key News
7.19 Chembio Diagnostics
7.19.1 Chembio Diagnostics Corporate Summary
7.19.2 Chembio Diagnostics Business Overview
7.19.3 Chembio Diagnostics Point of Care Rapid Diagnosis Major Product Offerings
7.19.4 Chembio Diagnostics Point of Care Rapid Diagnosis Sales and Revenue in Global (2017-2022)
7.19.5 Chembio Diagnostics Key News
7.20 Trinity Biotech
7.20.1 Trinity Biotech Corporate Summary
7.20.2 Trinity Biotech Business Overview
7.20.3 Trinity Biotech Point of Care Rapid Diagnosis Major Product Offerings
7.20.4 Trinity Biotech Point of Care Rapid Diagnosis Sales and Revenue in Global (2017-2022)
7.20.5 Trinity Biotech Key News
7.21 ELITech Group
7.21.1 ELITech Group Corporate Summary
7.21.2 ELITech Group Business Overview
7.21.3 ELITech Group Point of Care Rapid Diagnosis Major Product Offerings
7.21.4 ELITech Group Point of Care Rapid Diagnosis Sales and Revenue in Global (2017-2022)
7.21.5 ELITech Group Key News
7.22 Response Biomedical
7.22.1 Response Biomedical Corporate Summary
7.22.2 Response Biomedical Business Overview
7.22.3 Response Biomedical Point of Care Rapid Diagnosis Major Product Offerings
7.22.4 Response Biomedical Point of Care Rapid Diagnosis Sales and Revenue in Global (2017-2022)
7.22.5 Response Biomedical Key News
7.23 Princeton BioMeditech
7.23.1 Princeton BioMeditech Corporate Summary
7.23.2 Princeton BioMeditech Business Overview
7.23.3 Princeton BioMeditech Point of Care Rapid Diagnosis Major Product Offerings
7.23.4 Princeton BioMeditech Point of Care Rapid Diagnosis Sales and Revenue in Global (2017-2022)
7.23.5 Princeton BioMeditech Key News
7.24 Alfa Wassermann
7.24.1 Alfa Wassermann Corporate Summary
7.24.2 Alfa Wassermann Business Overview
7.24.3 Alfa Wassermann Point of Care Rapid Diagnosis Major Product Offerings
7.24.4 Alfa Wassermann Point of Care Rapid Diagnosis Sales and Revenue in Global (2017-2022)
7.24.5 Alfa Wassermann Key News
7.25 ARKRAY
7.25.1 ARKRAY Corporate Summary
7.25.2 ARKRAY Business Overview
7.25.3 ARKRAY Point of Care Rapid Diagnosis Major Product Offerings
7.25.4 ARKRAY Point of Care Rapid Diagnosis Sales and Revenue in Global (2017-2022)
7.25.5 ARKRAY Key News
8 Global Point of Care Rapid Diagnosis Production Capacity, Analysis
8.1 Global Point of Care Rapid Diagnosis Production Capacity, 2017-2028
8.2 Point of Care Rapid Diagnosis Production Capacity of Key Manufacturers in Global Market
8.3 Global Point of Care Rapid Diagnosis Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Point of Care Rapid Diagnosis Supply Chain Analysis
10.1 Point of Care Rapid Diagnosis Industry Value Chain
10.2 Point of Care Rapid Diagnosis Upstream Market
10.3 Point of Care Rapid Diagnosis Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Point of Care Rapid Diagnosis Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer